Australia's largest stock trading and investment forum Australia's #1 stock forum

TIS

Click for more information

0.00%

0.0¢ tissue therapies limited

"may be subject to other influences." Yes, I have often wondered...

First 40 Last

Share
Profile

Follow
riverbrae

2,515 Posts.

04/08/14

12:27

Post #: 13764567
Share

Originally posted by Revreboot ↑

We can but hope Surfrat.

It would seem likely that a "List of Outstanding Issues" is just that. In other words it would be unfair if EMA raised new issues at the next meeting which were not raised in the initial "List of Questions". That means that if TIS has performed due diligence and dotted every i and crossed every t from the original List of Questions then there should be no further delays and a positive opinion, subsequent granting of CE Mark and first sales should be in late September / early October.

Of course I'm trying to apply logic here to a process that may not be logical and may be subject to other influences.

Rev

Expand

"may be subject to other influences."

Yes, I have often wondered about that.
RB

TIS Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

HMC

HMC Capital snatches French Neoen's VIC-based renewables assets for $950M

LBT

AstraZeneca orders 4 more microbiological scanners from Clever Culture Systems for $3M

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 6 more messages in this thread...

First 40 Last

Add TIS (ASX) to my watchlist